Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
8 hedge funds and large institutions have $654K invested in Biocept, Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 15 closing their positions.
8.22% less ownership
Funds ownership: 8.22% → 0% (-8.2%)
42% less capital invested
Capital invested by funds: $1.12M → $654K (-$466K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
62% less funds holding
Funds holding: 21 → 8 (-13)
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$580K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$167K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$2.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$193K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$117K |
| 3 |
Barclays
London,
United Kingdom
|
-$109K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$105K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45.9K |
BIOC Hedge Fund Activity: Q3 2018 in Review
8 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2018, worth a combined $654K — down 42% from $1.12M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BIOC and 2 opened new positions — a net loss of 13 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $580K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $193K sold.
- 8 institutional investors held Biocept, Inc. (BIOC) as of Q3 2018, down from 21 in Q2 2018.
- Funds reported $654K of Biocept, Inc. stock for Q3 2018, down 42% quarter-over-quarter.
- 2 funds opened new Biocept, Inc. positions in Q3 2018 and 15 closed out, a net change of -13 holders.
- The largest Biocept, Inc. buyer in Q3 2018 was Sabby Management, an estimated $580K added.
- The largest Biocept, Inc. seller in Q3 2018 was Perkins Capital Management, an estimated $193K sold.
Based on aggregated 13F filings for Q3 2018.